Medical test · Infectious disease & microbiology · full clinical detail

HIV test

Also known as: HIV antibody test, fourth-generation HIV test, HIV screening test, HIV blood test

A blood test that looks for the human immunodeficiency virus, usually by detecting both a viral protein (p24 antigen) and the antibodies the immune system makes against the virus. Modern combined tests become positive within a few weeks of infection; a positive screening result is always confirmed with a second test before a diagnosis is given.

Open in the 3D explorerThymus anatomy
3D model of the Thymus in the Anatomy Nexus anatomy atlas
Interactive 3D model: Thymus. Orbit, zoom and click the structures.Load the 3D model
Canonical name
HIV antigen and antibody test
Abbreviations
HIV Ag/Ab
Kind
Laboratory test
Categories
Infectious disease & microbiology, Point-of-care & home testing
Specimen
Serum, Capillary (fingerprick) blood, Saliva
Method
Immunoassay, Point-of-care device, PCR (including RT-PCR and qPCR)
Terminology
LOINC 56888-1
Type
Blood test (serology; rapid and self-tests available)
Sample
Blood from a vein, a fingerprick, or saliva for self-tests
Used for
Screening for HIV, testing after exposure, monitoring treatment once diagnosed
Measures
HIV antibodies and p24 antigen; viral load and CD4 count after diagnosis
Result
Negative, reactive or confirmed positive; numeric viral load and CD4 count in monitoring

Why is it used?

  • Routine screening: HIV testing is offered widely because early treatment protects health and prevents transmission
  • After a possible exposure, at the right interval
  • Symptoms of seroconversion or of an immune system under attack
  • Pregnancy screening, before some treatments and in people diagnosed with other sexually transmitted infections

What does it measure?

MeasureWhat it tells you
HIV-1 and HIV-2 antibodies with p24 antigenThe standard fourth-generation laboratory screen, reliable from about 45 days after exposure; antigen detection shortens the window.
Rapid and self-testsFingerprick or saliva tests with results in minutes; a reactive result must be confirmed by a laboratory.
HIV RNA (viral load) and CD4 countAfter diagnosis: the amount of virus and the number of CD4 immune cells, used to plan and monitor treatment rather than to screen.

A high or low value can be associated with several different situations; the result is interpreted with other results, symptoms, history and clinical findings.

How is it performed?

A venous blood sample in a laboratory, a fingerprick rapid test in a clinic or pharmacy, or a home self-test kit.

Specimen. Venous blood (serum) in the laboratory; capillary blood or oral fluid for rapid and self-tests

Do I need to prepare?

None. The window period matters: a test taken too soon after exposure can be negative, so a repeat at the recommended interval may be advised.

What do the results generally mean?

FindingWhat it may indicate
Negative after the window periodHIV infection is very unlikely; repeat testing is advised after any further exposure
Reactive screening testPossible infection; a confirmatory laboratory test on a new sample is done before any diagnosis
Confirmed positiveHIV infection; referral to specialist care, where viral load and CD4 count guide antiretroviral treatment that keeps the virus suppressed
Negative inside the window periodInconclusive; the test is repeated at the interval recommended for the type of test used
Interpreted descriptively by a clinician, not against a numeric range. Screening results are reported as negative or reactive, and confirmed positive or negative; no numeric reference interval applies. Viral load and CD4 count after diagnosis are numbers interpreted against treatment guidelines.

What can affect the result?

  • The interval since exposure (window period), which depends on the test type
  • Post-exposure or pre-exposure prophylaxis medicines, which can delay antibody development
  • Rare false-reactive screening results, which is why confirmation is required

Medicines. Antiretroviral prophylaxis can delay or blunt antibody responses; antiretroviral treatment lowers the viral load, which the monitoring tests track.

What can the test not tell you?

  • Whether infection occurred within the last few weeks, before markers appear
  • The stage of infection or the state of the immune system, which need the viral load and CD4 count
  • Other sexually transmitted infections, which have their own tests

No test detects infection immediately after exposure; results are only interpreted in relation to the timing of exposure, and a screening result is never a diagnosis on its own. Self-tests carry the same window-period limits and need confirmation.

Other tests commonly used with it

Catalogued concepts this page covers

Concepts of the master test taxonomy that resolve to this page; each links to its category.

Educational content. Reference ranges differ between laboratories, methods, ages and sexes, and results are always read against the person, the question asked and other findings. This page cannot interpret an individual result.